Position history for WELLINGTON MANAGEMENT GROUP LLP's holdings in BRIDGEBIO ONCOLOGY THERAPEUT
WELLINGTON MANAGEMENT GROUP LLP holds 2.8M shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $25.2M as of 2026-Q1. The position was decreased (-3.0% shares). BBOT represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.
Current Value
$25.2M
Current Shares
2.8M
Total Value Change
-$9.1M
Total Shares Change
-142,915
Other major holders of BBOT: Alphabet Inc., CITADEL ADVISORS LLC, BlackRock, Inc.
Decreased |
| 2.8M |
-3.0% |
| $25.2M |
| 0.0% |
| $9.74 |
0 |
| 2025-Q4 | Decreased | 2.9M | -1.8% | $36.4M | 0.0% | $12.37 | 0 |
| 2025-Q3 | New | 3M | - | $34.3M | 0.0% | $11.47 | 40 |